EMPIRE CONSULTING GROUP

Lobbying for AMGEN INC. · Healthcare/Biotechnology

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 16, 2026

Lobbying activity 1

Health Issues

Issues related to health access. PBM reform. Most Favored Nation issues. 340B Reform. Issues related to Womens Health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.